Searchable abstracts of presentations at key conferences in endocrinology

ea0019p390 | Thyroid | SFEBES2009

The management of thyroid fine needle aspiration (FNA) cytology samples reported as benign (Thy2): an audit of practice at a teaching hospital

Whitelaw B , Augustin Y , Lo Q , Gilbert J

Introduction: Fine needle aspiration (FNA) is used, in conjunction with clinical assessment and imaging, to assess thyroid nodules for suspected malignancy. Cytological assessment of FNA samples involves both a text report and classification into a diagnostic category Thy1–Thy 5. The cytological category Thy 2 describes a FNA sample assessed to be non-neoplastic. Current BTA guidelines recommend two FNA samples, 3–6 months apart, are obtained to exclude neoplasia.</p...

ea0017p44 | (1) | BSPED2008

Clinical challenges in children with Type I diabetes mellitus aged less than 6 years old in a UK region

Anderson Y , De Palma A , Widmer B , Ong K , Acerini C

Objectives: To assess current clinical practice in children aged 0–5.99 years with Type I Diabetes Mellitus (T1DM).Methods: All paediatric diabetes centres (n=17) within a single UK region were asked to provide retrospective data for the year ending 01/12/07. 15 (88%) centres responded and provided data for each child on presentation, initial and current insulin regimens. Outcome measures were HbA1c, and acute hospital admissions post-diagnos...

ea0011s49 | How hormones get into cells | ECE2006

Cell surface carrier - mediated transport of steroid hormones

Steffgen J , Hagos Y , Asif A , Beéry E , Burckhardt G

Experimental data demonstrate interactions of steroids with efflux carriers of the multidrug-resistance transporter family (P-glycoprotein, MRP) as well as the poly-specific uptake carriers of the organic anion transporting polypetptide (OATP), organic cation transporter (OCT), and the organic anion transporter (OAT) families in different tissues.P-glycoprotein is associated with glucocorticoid-resistance of many diseases including cancer but also modula...

ea0011p141 | Clinical case reports | ECE2006

A rare cause of thyrotoxicosis and hypercalcemia

Murthy NPN , Prasad Y , Thomas M , Fiad T

A32 year old lady was admitted with symptoms of palpitations, tremors, insomnia, heat intolerance, weight loss and excessive perspiration for 4 weeks. Worsening of these symptoms with vomiting prompted the admission. She had similar episode 7 yrs ago following the birth of her child when a provisional diagnosis of postpartum thyrotoxicosis was made but lost follow up with in 2 weeks. She works as a carer looking after mentally handicapped children. Her mother suffers from hypo...

ea0011p146 | Clinical case reports | ECE2006

Using of pulse methylprednisolon therapy in Graves’ ophthalmopathy

Nechaeva O , Bardeeva Y , Perepelova O , Shestakova T , Chikh I

The aim of the study is to estimate the efficacy of intravenous corticosteroid therapy in patients with active, sever Graves’ ophthalmopathy.Material and methods: 16 patients with bilateral active, sever Graves’ ophthalmopathy were included to the study. Euthyroididsm has been provided, mean dose of methimasol therapy was 9.4±6.6 mg a day, median of TSH- 0.3 mlU/l, median of fT4 –15.3 pmol/l. The median of duration of GO was 6.5 month...

ea0011p156 | Clinical case reports | ECE2006

17beta-hydroxysteroid dehydrogenase deficiency caused by homozygous h271r mutation

Bachelot A , Chakhtoura Z , Kuttenn F , Morel Y , Touraine Ph

17β-hydroxysteroid dehydrogenase-3 (17βHSD3) deficiency is an autosomal recessive form of male pseudohermaphroditism due to impaired testicular conversion of androstenedione to testosterone. 46,XY homozygotes or compound heterozygotes for mutations of the HSD17B3 gene have testes and normally developed Wolffian duct derivatives, but they present with undervirilization of the external genitalia, which are often female. About twenty different mutations of the 17βH...

ea0011p199 | Clinical practise and governance | ECE2006

Clinical evaluation of sheehan syndrome

Kubat Uzum A , Mert M , Orhan Y , Ozbey N , Aral F

The term Sheehan syndrome refers to the development of pituitary necrosis due to ischemia within a few hours of delivery. Usually, antecedent hypotension and shock are present, resulting most commonly from obstetric hemorrhage. In such instances evidence of adrenal and thyroid insufficiency should be sought. A classical symptom of Sheehan’s syndrome is the absence of lactation after delivery related to prolactin deficiency. We retrospectively analysed 64 patients who were...

ea0011p298 | Diabetes, metabolism and cardiovascular | ECE2006

Gender distribution in Ukrainian adult insulin-treated diabetics depending of age at diagnosis

Tronko M , Khalangot M , Kravcenko V , Kulchinska Y , Vaiserman A

Background: The male preponderance among 15–30 yrs old patients with type 1 diabetes mellitus (T1DM) was repeatedly described. All-age gender distribution assessment was not done yet because of the difficulties in the type of DM recognition in insulin-treated (IT) patients diagnosed after 30 yrs of age. The possibility of such assessment has arisen from the use of population-based DM registers by patients stratification depending of their disease history.<p class="abs...

ea0011p319 | Diabetes, metabolism and cardiovascular | ECE2006

Effects of Ezetimibe on serum lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL cholesterol apheresis and high dose atorvastatin therapy

Azezli A , Bayraktaroglu T , Kutluturk F , Cikim A , Tanyolac S , Orhan Y

Homozygous familial hypercholesterolemia (HoFH) represents a potentially fatal condition that is caused by low density lipoprotein (LDL) cholesterol receptor deficiency. Statins alone are not effective in HoFH. In recent years, semiselective or selective LDL cholesterol apheresis systems have been shown to prolong life. However, applying LDLC apheresis therapy, recent evidence also suggests that more intense LDL cholesterol reduction is associated with more clinical benefit. E...

ea0011p320 | Diabetes, metabolism and cardiovascular | ECE2006

Effect of micronised fenofibrate on plasma levels of c-reactive protein in combined hyperlipidemia

Azezli A , Bayraktaroglu T , Kutluturk F , Cikim A , Tanyolac S , Orhan Y

C-reactive protein (CRP) is a non-specific but sensitive marker of underlying systemic inflammation. High CRP levels correlate with risk for future cardiovascular events. Statins can lower the circulating levels of CRP. In contrast, the evidence that fibrates lower CRP levels is very limited. This retrospective study evaluates the effect of micronised fenofibrate on plasma levels of CRP in patients with combined hyperlipidemia.Sixty-four patients with co...